World Niemann Pick C1 Like Protein 1 (NPC1L1) Therapeutics Pipeline Review 2016 - Research and Markets

DUBLIN--()--Research and Markets has announced the addition of the "Niemann Pick C1 Like Protein 1 (NPC1L1) - Pipeline Review, H1 2016" report to their offering.

Niemann Pick C1 Like Protein 1 (NPC1L1) Niemann-Pick C1-Like 1 (NPC1L1) is a gene associated with NPC1 which mutation results in Niemann-Pick disease. It is found on the gastrointestinal tract epithelial cells as well as in hepatocytes. It appears to bind to a critical mediator of cholesterol absorption.

Niemann Pick C1 Like Protein 1 (NPC1L1) pipeline Target constitutes close to 8 molecules. Out of which approximately 8 molecules are developed by Companies. The molecules developed by Companies in Pre-Registration, Phase III, Phase II and Preclinical stages are 2, 3, 2 and 1 respectively.

Niemann Pick C1 Like Protein 1 (NPC1L1) - Pipeline Review, H1 2016, outlays comprehensive information on the Niemann Pick C1 Like Protein 1 (NPC1L1) targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews key players involved in Niemann Pick C1 Like Protein 1 (NPC1L1) targeted therapeutics development, features dormant and discontinued projects and latest news and press releases.

Key Topics Covered:

  1. Introduction
  2. Niemann Pick C1 Like Protein 1 Overview
  3. Therapeutics Development
  4. Pipeline Products for Niemann Pick C1 Like Protein 1 - Overview
  5. Pipeline Products for Niemann Pick C1 Like Protein 1 - Comparative Analysis
  6. Niemann Pick C1 Like Protein 1 - Therapeutics under Development by Companies
  7. Niemann Pick C1 Like Protein 1 - Therapeutics under Investigation by Universities/Institutes
  8. Niemann Pick C1 Like Protein 1 Products Glance
  9. Late Stage Products
  10. Clinical Stage Products
  11. Early Stage Products
  12. Niemann Pick C1 Like Protein 1 - Products under Development by Companies
  13. Niemann Pick C1 Like Protein 1 - Products under Investigation by Universities/Institutes
  14. Niemann Pick C1 Like Protein 1 - Companies Involved in Therapeutics Development
  • Alvogen Korea Co., Ltd.
  • Chong Kun Dang Pharmaceutical Corp.
  • CJ HealthCare Corp.
  • Esperion Therapeutics, Inc.
  • Kotobuki Pharmaceutical Co., Ltd.
  • Merck & Co., Inc.
  • Zhejiang Hisun Pharmaceutical Co., Ltd.

For more information about this report visit http://www.researchandmarkets.com/research/j9j57g/niemann_pick_c1

Related Topics: Infectious Diseases Drugs

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716